| Literature DB >> 26799209 |
Aneta A Koronowicz1, Aneta Kopeć1, Adam Master2, Sylwester Smoleń3, Ewa Piątkowska1, Renata Bieżanowska-Kopeć1, Iwona Ledwożyw-Smoleń4, Łukasz Skoczylas5, Roksana Rakoczy3, Teresa Leszczyńska1, Joanna Kapusta-Duch1, Mirosław Pysz1.
Abstract
Although iodization of salt is the most common method used to obtain iodine-enriched food, iodine deficiency disorders are still a global health problem and profoundly affect the quality of human life. Iodine is required for the synthesis of thyroid hormones, which are crucial regulators of human metabolism, cell growth, proliferation, apoptosis and have been reported to be involved in carcinogenesis. In this study, for the first time, we evaluated the effect of iodine-biofortified lettuce on transcriptomic profile of Caco-2 cancer cell line by applying the Whole Human Genome Microarray assay. We showed 1326 differentially expressed Caco-2 transcripts after treatment with iodine-biofortified (BFL) and non-fortified (NFL) lettuce extracts. We analysed pathways, molecular functions, biological processes and protein classes based on comparison between BFL and NFL specific genes. Iodine, which was expected to act as a free ion (KI-NFL) or at least in part to be incorporated into lettuce macromolecules (BFL), differently regulated pathways of numerous transcription factors leading to different cellular effects. In this study we showed the inhibition of Caco-2 cells proliferation after treatment with BFL, but not potassium iodide (KI), and BFL-mediated induction of mitochondrial apoptosis and/or cell differentiation. Our results showed that iodine-biofortified plants can be effectively used by cells as an alternative source of this trace element. Moreover, the observed differences in action of both iodine sources may suggest a potential of BFL in cancer treatment.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26799209 PMCID: PMC4723252 DOI: 10.1371/journal.pone.0147336
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Effect of iodine-biofortified lettuce on Caco-2 cell proliferation.
Values are expressed as means ± SEM for the N ≥ 9, standarized to NC as 100%. Statistical significance was based on Student's t-test * p < 0.05 versus (vs). NC and ^ p < 0.05 vs. NFL.
Analysis of differentially expressed transcripts between experimental groups in Caco-2 cell line.
| Group Name | BFL | NFL | NC |
|---|---|---|---|
| 1326 | 2014 | ||
| 1277 | 2448 | ||
| 589 | 155 |
Statistical significance of treatment: p < 0.05
* transcripts differentially expressed between compared groups
# common transcripts between compared groups
• all the analyzed transcripts
NC negative control of Caco-2 cells
Iodine-biofortified lettuce specific genes in response to iodine in Caco-2 cell line.
| Gene Symbol | Adjusted p-values | FC value | Gene Name |
|---|---|---|---|
| 3.31E-04 | -2.54 | Heme Oxygenase | |
| 7.62E-04 | -1.64 | Thyroid Hormone Receptor, Beta | |
| 2.81E-03 | -1.53 | Glucose-6-Phosphate Dehydrogenase | |
| 4.43E-03 | -1.39 | Atp-Binding Cassette, Sub-Family B | |
| 2.03E-04 | -1.37 | Fbj Murine Osteosarcoma Viral Oncogene Homolog | |
| 3.11E-05 | -1.30 | Nitric Oxide Synthase 2, Inducible | |
| 1.01E-03 | -1.25 | Thioredoxin | |
| 3.14E-05 | -1.08 | Peroxisome Proliferator-Activated Receptor Gamma | |
| 3.25E-03 | 1.27 | Insulin-Like Growth Factor 1 Receptor | |
| 4.13E-04 | 1.39 | Glutathione Peroxidase 1 | |
| 1.15E-03 | 1.45 | Thyroglobulin | |
| 1.53E-04 | 1.45 | Natriuretic Peptide B | |
| 1.22E-06 | 1.53 | Solute Carrier Family 6 | |
| 4.99E-04 | 1.56 | Myosin Light Chain Kinase |
Statistical significance of treatment: p < 0.05
Fig 2Regulation of BFL specific genes in response to iodine in Caco-2 cell line.
Fig 3Interrelationships between BFL specific genes in response to iodine.
RTqPCR analysis of BFL vs. NFL and KI vs. NFL in Caco-2 cell line.
| Gene Symbol | Adjusted BFL/NFL p-values | FC value BFL/NFL RTqPCR | FC value BFL/NFL Microarray | Adjusted KI/NFL p-values | FC value KI/NFL RTqPCR | Gene name |
|---|---|---|---|---|---|---|
| 9.62E-01 | 1.01E+00NS | -1.01E+00NS | 6.50E-01 | 1.13E+00NS | Thyroid Hormone Receptor, Alpha | |
| -1.33E+00 | -1.64E+00 | -1.07E+00 | Thyroid Hormone Receptor, Beta | |||
| 1.89E+00 | 1.90E+00 | 2.67E+00 | Deiodinase, Iodothyronine, Type I | |||
| -1.89E+00 | -1.14E+00 | 1.58E+00 | E2F Transcription Factor 1 |
Statistical significance of treatment: p < 0.05
NS, non-significant
Pathways based on BFL vs. NFL specific genes differentially regulated in Caco-2 cell line.
| Pathway | The number of genes involved in pathway | The symbol of regulated gen | |
|---|---|---|---|
| 225 | 1.04E-02 | ||
| 163 | 3.37E-03 | ||
| 122 | 6.58E-03 | ||
| 107 | 2.99E-02 | ||
| 115 | 4.59E-02 | ||
| 41 | 2.34E-02 | ||
| 22 | 6.83E-03 | ||
| 22 | 3.07E-02 | ||
| 11 | 2.14E-02 |
Statistical significance of treatment: p < 0.05